NCT05584085

Brief Summary

This study will evaluate the effectiveness of a structured acceptance-based diabetes education programme for adults with type 2 diabetes compared with those who received diabetes education. The programme mainly comprises acceptance and commitment therapy (ACT) as a psychological component and a diabetes education (DE) component. The short form of the programme is named 'ACT-DE'. This programme aims to decrease the diabetes distress level in participants with type 2 diabetes and improve their blood glucose level. The objectives are:

  1. 1.To develop an ACT-based intervention protocol as a guide for promoting healthy coping in people with type 2 diabetes who are psychologically distressed.
  2. 2.To examine the effects of 'ACT-DE' on diabetes distress and HbA1c (primary outcomes) over a three-month follow-up, when compared with diabetes education only.
  3. 3.To examine the effects of 'ACT-DE' on diabetes self-management behaviours, self-efficacy in diabetes care, and psychological flexibility (secondary outcomes) over the three-month follow-up, when compared with diabetes education; and
  4. 4.To identify the relationships between psychological flexibility and diabetes self-efficacy, diabetes self-management behaviour and HbA1c among the study participants

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
176

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

October 15, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 18, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

11 months

First QC Date

October 5, 2022

Last Update Submit

February 6, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline Diabetes Distress Scale at 3 months post intervention

    Diabetes distress will be measured by the Chinese 15-item Diabetes Distress Scale (CDDS-15). It consists of 15 items. rated on a six-point Likert scale from 1 = 'not a problem' to 6 = 'a serious problem'. A mean item score of 2-2.9 and ≥3.0 indicates moderate and severe distress, respectively.

    Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)

  • Change from baseline HbA1c at 3 months post-intervention

    Blood glucose level of participants will be evaluated with an HbA1c level, which measures the average blood glucose level during the past three months. An HbA1c level over 7% is considered suboptimal glycaemic control, indicating a high risk of diabetes complications.2 HbA1c values obtained every 3-4 months will be collected from the patient electronic information system.

    Baseline (T0), and 3-month post-intervention (T2)

Secondary Outcomes (3)

  • Diabetes self-management behaviours

    Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)

  • Diabetes management self-efficacy

    Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)

  • Psychological flexibility

    Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)

Study Arms (2)

Acceptance and commitment therapy integrated in diabetes education (ACT-DE)

EXPERIMENTAL

The proposed intervention is a six-week acceptance-based diabetes education programme (ACT-DE) comprising acceptance and commitment therapy and diabetes education. Session 1: Diabetes education and introduction of ACT-DE programme Session 2: Mindfulness cultivation Session 3: Value clarification Session 4: Integrating ACT into diabetes self-management Session 5: Booster session Session length: 120 minutes Group-based (6-8 participants) and face-to-face mode of delivery

Behavioral: ACT-DE

Diabetes education

PLACEBO COMPARATOR

One session of diabetes education, group-based (6-8 participants) and 120 minutes via face-to-face delivery.

Behavioral: ACT-DE

Interventions

ACT-DEBEHAVIORAL

Acceptance and Commitment Therapy is a third-wave psychological therapy to cultivate participants' acceptance attitude to diabetes and motivate them for a value-driven persistent diabetes self-management, directed by six psychological processes in the ACT hexagonal model, including acceptance, cognitive defusion, the present moment, self-as-context, value clarification and committed action.

Acceptance and commitment therapy integrated in diabetes education (ACT-DE)Diabetes education

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • community-dwelling adults Hong Kong Chinese residents,
  • aged 18-64,
  • diagnosed with type 2 diabetes for over one year;
  • at least moderate level of diabetes distress as measured with the Chinese
  • Diabetes Distress Scale (CDDS-15; mean score \>2 per item);
  • having suboptimal blood glucose control as shown by HbA1c level of ≥ 7% in the laboratory results within the past six months;
  • able to communicate in Cantonese and give written consent

You may not qualify if:

  • history of a clinically diagnosed mental illness such as depression and anxiety disorder, and/or an acute/severe medical disease;
  • noticeable cognitive impairment(s) as indicated by the total score (\<6 of 10) of the Abbreviated Mental Test;
  • recently received/receiving any psychological therapy such as mindfulness or acceptance-based therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Nethersole School of Nursing

Hong Kong, Hong Kong Island, Hong Kong

RECRUITING

Central Study Contacts

Anna Ngan, PhD candidate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor who is responsible for collecting outcome data and data entry has no idea about the group allocation or participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly allocated (1:1 ratio) to either the intervention group that receive 1 6-week ACT-DE programme, while participants in the control group receive one session of diabetes education.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

October 5, 2022

First Posted

October 18, 2022

Study Start

October 15, 2022

Primary Completion

August 31, 2023

Study Completion

November 30, 2023

Last Updated

February 8, 2023

Record last verified: 2023-02

Locations